Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Other Working Capital Changes (2016 - 2025)

Iradimed (IRMD) has disclosed Other Working Capital Changes for 13 consecutive years, with -$421937.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes fell 337.33% to -$421937.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$98881.0, a 110.05% decrease, with the full-year FY2024 number at $320233.0, down 43.07% from a year prior.
  • Other Working Capital Changes was -$421937.0 for Q3 2025 at Iradimed, down from -$1510.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.2 million in Q2 2021 to a low of -$1.2 million in Q3 2021.
  • A 5-year average of $63077.9 and a median of $3759.0 in 2022 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: skyrocketed 1430.37% in 2021, then crashed 9695.8% in 2023.
  • Iradimed's Other Working Capital Changes stood at $724666.0 in 2021, then tumbled by 141.3% to -$299276.0 in 2022, then surged by 427.71% to $980761.0 in 2023, then plummeted by 67.63% to $317469.0 in 2024, then crashed by 232.91% to -$421937.0 in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Other Working Capital Changes are -$421937.0 (Q3 2025), -$1510.0 (Q2 2025), and $7097.0 (Q1 2025).